What does the evidence say about Vitamin K2 Bone Health Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Vitamin K2 Bone Health Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Vitamin D deficiency has been consistently associated with adverse outcomes, including increased susceptibility to cancers, diabetes, hypertension, and cardiovascular disease [,]. [D&#8217;Elia Saverio (2025); evidence level 3] - Epidemiological studies further indicate that populations in regions with higher sun exposure exhibit lower prevalence of deficiency and reduced mortality from chronic disease [,]. [D&#8217;Elia Saverio (2025); evidence level 3] - These findings are reinforced by recent large-scale analyses: for example, a 2023 study in Clinical Nutrition involving nearly 410,000 UK Biobank participants reported that individuals with severe deficiency (<30 nmol/L) had a 10% increased risk of atherosclerotic cardiovascular disease and up to 35% higher risk of cardiovascular mortality []. [D&#8217;Elia Saverio (2025); evidence level 3] - 1 2 3 4 5 6 7 6 Vitamin D, a pleiotropic secosteroid, exerts physiological effects far beyond its classical roles in calcium homeostasis and skeletal health []. [D&#8217;Elia Saverio (2025); evidence level 3] - 14 15 11 12 16 17 18 Epidemiological studies support this notion, reporting that higher vitamin K status is associated with better physical performance and lower risk of mobility limitation in older adults (,). [Ran Xiaoyu (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.